Castellan Group’s Medpace MEDP Stock Holding History

Castellan Group’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-16,821	Closed	-$6.93M	–	63
2024 Q2	$6.93M	Buy	16,821 +768	+5%	+$304K	3.3%	4
2024 Q1	$6.49M	Buy	16,053 +1,573	+11%	+$553K	3.32%	5
2023 Q4	$4.44M	Buy	+14,480	New	+$3.91M	2.76%	7

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Castellan Group's MEDP Position: Q3 2024 in Review

Castellan Group sold out of Medpace (MEDP) in Q3 2024, closing a stake of 16,821 shares — an estimated $6.93M sold.

Castellan Group first reported a position in MEDP in Q4 2023 and held it in 3 quarters. The position peaked at $6.93M in Q2 2024. 583 funds tracked by Wall St. Rank hold MEDP as of Q3 2024.

Castellan Group reported no remaining Medpace position as of Q3 2024 after selling out during the quarter.
Castellan Group sold 16,821 Medpace shares in Q3 2024, an estimated $6.93M.
Castellan Group first reported a position in Medpace in Q4 2023 and held it in 3 quarters.
Castellan Group's Medpace position peaked at $6.93M in Q2 2024.
583 funds tracked by Wall St. Rank held Medpace as of Q3 2024.

Based on Castellan Group's 13F filing for Q3 2024, filed 25 Nov 2024.